Guardant Health, Inc. Common Stock Earnings Dividend
Earnings Summary
Revenue | $334.98Mn |
Net Profits | $-120.14Mn |
Net Profit Margins | -35.87% |
Guardant Health, Inc. Common Stock’s revenue jumped 44.33% since last year same period to $334.98Mn in the Q2 2026. On a quarterly growth basis, Guardant Health, Inc. Common Stock has generated 11.04% jump in its revenue since last 3-months.
Guardant Health, Inc. Common Stock’s net profit fell -20.26% since last year same period to $-120.14Mn in the Q2 2026. On a quarterly growth basis, Guardant Health, Inc. Common Stock has generated -7.2% fall in its net profits since last 3-months.
Guardant Health, Inc. Common Stock’s net profit margin jumped 16.68% since last year same period to -35.87% in the Q2 2026. On a quarterly growth basis, Guardant Health, Inc. Common Stock has generated 3.46% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.65 |
EPS Estimate Current Year | -0.65 |
Guardant Health, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -0.65 - a 12.16% jump from last quarter’s estimates.
Guardant Health, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -0.65.
Key Ratios
Earning Per Share (EPS) | -0.89 |
Guardant Health, Inc. Common Stock’s earning per share (EPS) fell -102.27% since last year same period to -0.89 in the Q2 2026. This indicates that the Guardant Health, Inc. Common Stock has generated -102.27% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-07 | -0.47 | -0.45 | 4.26% |
2026-07-30 | -0.74 | -0.89 | -20.27% |
